Alzchem confronts capacity pressures as demand for creatine booms
“Creatine is skyrocketing,” said Robert Alber, vice president of human nutrition at the Alzchem Group. “New trends in…
Jenerise launches creatine with SGS verification
Founded in 2024 by father-daughter duo Steve and Rachael Jennings, Jenerise is UK-based ingredient and supplement company that…
OmniActive’s Capsimax may work as a GLP-1 ‘booster’
In a randomized clinical study recently published in the Academic Journal of Sports Science & Medicine, scientists from…
Tips to help choose over-the-counter medications safely and wisely – The Irish Times
Over-the-counter (OTC) medications help people cure some simple diseases easily and without seeing a doctor. Some OTC drugs…
BYHEALTH’s protein upgrade, MIRIQA’s immunity debut, Elevit in brand round-up
BYHEALTH Zhenzuan Protein Powder (BYHEALTH) Protein consumption is growing in China across different consumer groups and demand for…
No medicine supply issues for private hospitals despite Middle East war
PETALING JAYA: Private hospitals in the country are not experiencing any disruptions in the supply of medications despite…
GLP-1 RA generics have arrived. Could we buy semaglutide made for just $4?
Semaglutide is now generic. Just not in Australia. But in China, Brazil and Canada, generic drug makers are…
Trump Touts Drug Cost Savings in TrumpRx Website Launch
President Donald Trump launched a new website to help Americans directly buy select medicines at a discount, seeking…
LibreOffice 26.2 gives users a faster, more polished office suite
LibreOffice 26.2 is now available, making it easier for users to create, edit, and share documents. Designed for…
New adrenaline nasal spray a 30-year first for Australia
The first nasal spray version of adrenaline is about to arrive in Australia, costing $194 for a two-pack. Branded…
Pura Collagen enters GLP-1 market with ‘pure’ hormone stimulating alternative
The two innovations expand the startup’s product line to seven, indicating the depth of consideration that goes into…
Obesity, M&A, Biotech Resurgence: A 2026 Guide to Health Stocks
The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth…